Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Op-Ed Việt Nam’s COVID-19 crisis response can increase opportunities for the country to emerge as a leader at regional and global levels
Media-OutReach Newswire Businesses Put People First as Singapore Prepares to Return to the Workplace after COVID-19: Aon’s Pulse Survey